We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

A picture of Sarah Whelan, PhD

Sarah Whelan, PhD profile page

Science Writer

 at Technology Networks

Sarah joined Technology Networks in 2022 after completing a PhD in cancer biology, where her research focused on the development of colon cancers. In her role as science writer and editor, Sarah covers scientific news and a range of other content types, leading the site's coverage of drug discovery, biopharma and cancer research content.


University of Kent  

University of Leicester  

Areas of Expertise

Got a Question for Sarah Whelan, PhD?

Get in touch using the contact form linked here and we’ll get back to you shortly

Published Content
Total: 281
A person undergoing an eye exam.

Study Links Popular Weight Loss Drug to Risk of Rare Blinding Condition

People prescribed the diabetes/weight loss drug semaglutide (also known as Ozempic or Wegovy) have an increased risk of a potentially blinding eye condition, according to a new study from Mass Eye and Ear researchers.
A person with an IV placed in their hand.

Nearly Half of Cancer Cases Are Linked to Modifiable Risk Factors, Study Finds

A new study has found that 40% of cancer cases, and nearly 50% of all cancer deaths, are linked to “modifiable risk factors” such as cigarette smoking, excess body weight and alcohol consumption.
A person drawing up a vaccine in a syringe.

RSV Vaccine in Pregnancy Not Associated With Increased Preterm Birth Risk, Study Finds

A new study has found that a vaccine against respiratory syncytial virus (RSV) administered during pregnancy was not associated with increased risks of preterm birth or other poor outcomes.
Antibodies in Screening infographic snippet

Antibodies in Screening

Download this infographic to learn more about therapeutic antibodies and their applications, the development of therapeutic antibodies and how high-throughput screening approaches and AI may enable antibody development.

An example of a Mediterranean-style salad.

Mediterranean Diet Linked to Lower Mortality for Cancer Survivors, Study Finds

Researchers have found that adhering to the Mediterranean diet – known for being rich in vegetables and whole grains and low in sugar and salt – can reduce the risk of mortality for cancer survivors.
A person pointing at and interpreting some brain scans.

New Alzheimer’s Drug Donanemab Approved by FDA

The drug donanemab (also known as Kisunla™) has been approved by the US Food and Drug Administration (FDA) for the treatment of adults with early symptomatic Alzheimer’s disease (AD).
Various cell types inside SemaCyte wells.
Industry Insight

Semarion Wins SLAS Europe Ignite Award 2024

At SLAS Europe 2024, Technology Networks had the pleasure of speaking with Jeroen Verheyen, CEO of Semarion, to discuss their award-winning work and how technological innovations advance research.
An illustration of the inside of the gut.

How Algae Microrobots Could Tackle Inflammatory Bowel Disease

University of California San Diego (UCSD) researchers have developed algae-based “microrobots” that reduce inflammatory bowel disease (IBD) symptoms in mouse models.
A person laying in bed wearing a CPAP mask for sleep apnea.

Antidiabetic Drug Tirzepatide Could Benefit Sleep Apnea Patients

A new clinical trial suggests that an antidiabetic drug, tirzepatide, could effectively treat obstructive sleep apnea (OSA). These data could pave the way to improved quality of life for people affected by the sleep-related disorder.
A glowing gold trophy.
Industry Insight

SLAS Europe 2024 New Product Award Winners

Two winners earned the New Product Award at SLAS Europe 2024: SEED Biosciences’ Dispen3D and Cryologyx’s PlateReady™. Technology Networks spoke with CEO of CryoLogyx Tom Congdon to learn more about their award-winning new product.